Dermatol. praxi. 2008;2(5):236-239

Lyme disease - biology, pathogenesis, diagnostics and treatment

Mgr. Michal Křupka, MUDr. Mgr. Milan Raška Ph.D, prof. MUDr. Evžen Weigl CSc
Ústav imunologie, Lékařská fakulta Univerzity Palackého, Olomouc

Paper reviews basic facts about pathogenesis, diagnostics, prevention and treatment of Lyme disease. This multisystemic disease is the most frequent zoonosis in Europe and the USA. The disease affects not only skin, but also nervous system, motoric apparatus, and cardiovascular system. Causative agent of the disease are spirochtetes from Borrelia burgdorferi species group. In spite of considerable research progress in recent decades, some features of this disease remain obscure. Similarly, the problem of vaccination is still unresolved.

Keywords: Lyme disease, Borrelia burgdorferi, spirochaetes

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Křupka M, Raška M, Weigl E. Lyme disease - biology, pathogenesis, diagnostics and treatment. Dermatol. praxi. 2008;2(5):236-239.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Asbrink E. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes. Acta Derm Venereol Suppl (Stockh). 1985; 118: 1-63. Go to PubMed...
    2. Bartůněk P. Historie. In: Bartůněk P, a kol. Lymeská borelióza. Praha: Grada publishing, 2006: 11.
    3. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tickborne spirochetosis? Science. 1982; 216:1317-1319. Go to original source... Go to PubMed...
    4. Breier FH, Aberer E, Stanek G, Khanakaha G, Schlick A, Tappeiner G. Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol. 1999; 140: 925-930. Go to original source... Go to PubMed...
    5. Brzonova I, Wollenberg A, Prinz JC. Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl. British Journal of Dermatology 2002; 147: 375-378. Go to original source... Go to PubMed...
    6. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998; 281: 703-706. Go to original source... Go to PubMed...
    7. Hercogová J, Dobrá N, Vaňousová D. Lymeská borelióza. Čes-slov. Derm. 2005; 80: 309-320.
    8. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001; 345: 85-92. Go to original source... Go to PubMed...
    9. Křupka M, Raška M, Běláková J, Horynová M, Novotný R, Weigl E. Biological aspects of Lyme disease spirochetes: Unique bacteria of the Borrelia burgdorferi species group. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007: 175-186. Go to original source...
    10. Kuenzle S, von Büdingen H-Ch, Meier M, Harrer MD, Urich E, Becher B, Goebels N. Pathogen Specificity and Autoimmunity Are Distinct Features of Antigen-Driven Immune Responses in Neuroborreliosis. Infect. Immun. 2007; 75: 3842-3847. Go to original source... Go to PubMed...
    11. Malawista SE, de Boisfleury Chevance A. Clocking the Lyme Spirochete. PLoS ONE 3(2): e1633.doi:10.1371/journal.pone.0001633; 2008. Go to original source...
    12. Maraspin V, Cimperman J, Lotric-Furlan S, Ruzić-Sabljić E, Jurca T, Picken RN, Strle F. Solitary borrelial lymphocytoma in adult patiens. Wien Klin Wochenschr. 2002; 114: 515-523.
    13. Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS. 2004; 112: 57-62. Go to original source... Go to PubMed...
    14. Müllegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004; 14: 296-309.
    15. Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Agüero-Rosenfeld ME, Dennis DT, Wormser GP, Tick Bite Study Group. Prophylaxis with singledose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001; 345: 79-84. Go to original source... Go to PubMed...
    16. Neubert U, Gerstner H, Meuer M, et al. Spirochetal antibodies in. morphea. J Invest Dermatol 1986; 86: 336.
    17. Schnepp C, Bocklage H, Lange R, et al. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Incest Dermatos 1993; 100: 717-720. Go to original source... Go to PubMed...
    18. Stanek G, Kahl O. Chemoprophylaxis for Lyme borreliosis? Zentralbl Bakteriol. 1999; 289: 655-665. Go to original source... Go to PubMed...
    19. Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol. 2000; 142: 636-644. Go to original source... Go to PubMed...
    20. Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, Ernerudh J. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis. 2004; 189: 1881-1891. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.